“…The first thing that stands out is that all the study authors belong to high-and upper-middle-income countries, not including authors from lower-and lower-middleincome countries, making it impossible to visualize SR production in the latter countries. Thus, socioeconomic difficulties and attention to health inequities and not only academic, technological, or translation-related barriers can interrupt the performance of SRs in developing countries [1] . Furthermore, despite the efforts of non-governmental entities, such as Cochrane, to optimize the production of this type of study, approximately developed countries produce about 200 times more SRs than low-income countries [2] .…”